Compare, Analyse with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   MYLAN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
MYLAN
Dec-18
ALKEM LABORATORIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs2,7203,521-   
Low Rs1,6601,938-   
Sales per share (Unadj.) Rs697.91,620.4-  
Earnings per share (Unadj.) Rs96.144.0-  
Cash flow per share (Unadj.) Rs117.3347.4-  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs515.21,752.9-  
Shares outstanding (eoy) m119.57514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.11.7 186.3%   
Avg P/E ratio x22.862.0 36.7%  
P/CF ratio (eoy) x18.77.9 237.7%  
Price / Book Value ratio x4.31.6 273.0%  
Dividend payout %26.00-   
Avg Mkt Cap Rs m261,8791,404,514 18.6%   
No. of employees `00014.335.0 40.9%   
Total wages/salary Rs m15,0550-   
Avg. sales/employee Rs Th5,822.623,819.4 24.4%   
Avg. wages/employee Rs Th1,050.50-   
Avg. net profit/employee Rs Th802.0646.8 124.0%   
INCOME DATA
Net Sales Rs m83,444833,681 10.0%  
Other income Rs m1,0420-   
Total revenues Rs m84,486833,681 10.1%   
Gross profit Rs m14,734215,726 6.8%  
Depreciation Rs m2,528156,098 1.6%   
Interest Rs m65140,097 1.6%   
Profit before tax Rs m12,59819,531 64.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105-3,107 -35.6%   
Profit after tax Rs m11,49322,638 50.8%  
Gross profit margin %17.725.9 68.2%  
Effective tax rate %8.8-15.9 -55.1%   
Net profit margin %13.82.7 507.2%  
BALANCE SHEET DATA
Current assets Rs m54,960465,527 11.8%   
Current liabilities Rs m32,433339,420 9.6%   
Net working cap to sales %27.015.1 178.5%  
Current ratio x1.71.4 123.6%  
Inventory Days Days8084 95.2%  
Debtors Days Days7293 77.3%  
Net fixed assets Rs m32,710161,720 20.2%   
Share capital Rs m239444 53.9%   
"Free" reserves Rs m61,3680-   
Net worth Rs m61,607901,890 6.8%   
Long term debt Rs m1,592973,429 0.2%   
Total assets Rs m99,4332,419,220 4.1%  
Interest coverage x20.41.5 1,369.4%   
Debt to equity ratio x01.1 2.4%  
Sales to assets ratio x0.80.3 243.5%   
Return on assets %12.22.6 471.0%  
Return on equity %18.72.5 743.2%  
Return on capital %21.03.2 659.3%  
Exports to sales %19.10-   
Imports to sales %3.00-   
Net fx Rs m13,5780-   
CASH FLOW
From Operations Rs m5,851173,239 3.4%  
From Investments Rs m-7,414-89,545 8.3%  
From Financial Activity Rs m792-80,705 -1.0%  
Net Cashflow Rs m-7311,435 -50.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.98 Rs / USD

Compare ALKEM LABORATORIES With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: VENUS REMEDIES  STRIDES PHARMA SCIENCE  PIRAMAL ENTERPRISES  SUN PHARMA  DR. DATSONS LABS  



Today's Market

4 Factors Behind the Sensex Rally, Maruti Suzuki February Sales, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed positive trading activity throughout the day yesterday and ended on a strong note.

Related Views On News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ALKEM LABORATORIES SHARE PRICE


Mar 1, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS